Latest Content

Patients with advanced stomach cancer lived longer on sonesitatug vedotin than on standard treatment, according to new trial results.

A pediatric oncologist explains what families should know after childhood cancer treatment, from long-term side effects to emotional recovery.

Serene Hesri was 25 when Hodgkin lymphoma was diagnosed. After relapsing, she enrolled in a clinical trial — and has been in remission for five years.

Sarah Velasquez, BSN, RN, OCN, of MD Anderson Cancer Center, goes above and beyond for her chronic lymphocytic leukemia patients through thorough communication and proactive advocacy.

Kristie Kahl of CURE spoke with Nicole Wright Dirks, a volunteer with Blue Faery, a patient advocacy organization focused on liver cancer.

Sharon Dix, of ThedaCare Appleton, quietly goes above and beyond for her cancer patients — picking up extra shifts, housing a patient's wife and keeping promises at every turn.

A factory shift became a painful reminder that breast cancer surgery and survivorship can leave lasting physical effects years after treatment.

When do cancer treatment side effects outweigh the benefits? One woman shares how she decided it was time to prioritize quality of life.

Tecvayli plus Talvey cut the risk of disease progression or death by 89% in patients with relapsed multiple myeloma, according to new trial results.

Dr. Paul Oberstein discusses RASolute 302, a pancreatic cancer trial, and what a potential KRAS inhibitor breakthrough could mean for patients.

Dr. Mark Zhao of UCSF Health discusses how TAMIS and single-port robotic surgery give select rectal cancer patients less invasive care and faster recovery.

Living with metastatic breast cancer means balancing hope, fear and reality. One survivor shares why words of support can sometimes miss the mark.

Serene Hesri was diagnosed with Hodgkin's lymphoma at 25. After a relapse, she enrolled in a clinical trial — and hasn't looked back since.